Research Article
Anti-Hepatitis B Virus X Protein in Sera Is One of the Markers of Development of Liver Cirrhosis and Liver Cancer Mediated by HBV
Table 1
Examination of HBV serum markers in CHB, LC, and HCC patients.
| | Diseases | No. | HBsAg (%) | Anti-HBs (%) | HBeAg (%) | Anti-HBe (%) | Anti-HBc (%) | HBxAg (%) | Anti-HBx (IgG) (%) |
| | CHB | 173 | 172 (99.4) | 5 (2.9) | 71 (41.0) | 120 (69.3) | 173 (100) | 15 (8.7) | 18 (10.4 ) | | LC | 106 | 86 (81.1) | 9 (8.5) | 48 (45.3) | 82 (77.4) | 105 (99.1) | 19 (17.9) | 43 (40.6 | | HCC | 61 | 46 (75.4) | 5 (8.2) | 17 (27.9) | 45 (73.8) | 56 (91.8) | 6 (9.8) | 21 (34.4 |
|
|
CHB chronic hepatitis B; LC liver cirrhosis; HCC hepatocellular carcinoma. test, (versus CHB).
|
